Use of megalin in urine as marker for detecting renal disorder
This invention provides a simple means for detecting a renal disorder, a diagnostic marker for a renal disorder that enables prognostic prediction of a renal disorder (e.g., diabetic nephropathy and IgA nephropathy) and evaluation of the degree of nephropathy at the phase of stage-II diabetic nephropathy by measuring the megalin level in urine associated with a renal disorder used for the detection means, and use of such marker. The invention also provides the use of human megalin obtained from the urine sample of a subject as a marker for detecting a renal disorder.
1. A method for detecting and treating a renal disorder in a subject, the method comprises:
(i) measuring a human megalin level in a urine sample;
(ii) determining the status or the degree of the renal disorder based on the human megalin level of step (i), wherein an increased level of human meglin comparing to a normal healthy subject indicates the renal disorder; and
(iii) treating the subject with a suitable therapy based on the status or the degree of the renal disorder determined by step (ii),
wherein the renal disorder is selected from the group consisting of diabetic nephropathy, IgA nephropathy, acute renal failure, nephritic syndrome, chronic glomerulonephritis, membranous nephropathy, ANCA-associated glomerulonephritis, lupus glomerulonephritis, Henoch-Schönlein purpura nephritis, crescentic glomerulonephritis, focal glomerulosclerosis, acute renal failure, chronic renal failure, scleroderma renal crisis, post-transplant renal disorder, and interstitial glomerulonephritis caused by Sjogren's syndrome.
2. The method according to claim 1 , wherein the renal disorder is detected for prognostic prediction.
3. The method according to claim 2 , wherein the prognostic prediction of a renal disorder is performed to evaluate tubular dysfunctions.
4. The method according to claim 1 , wherein the renal disorder is detected to evaluate the degree of disorder.
5. The method according to claim 4 , wherein the degree of renal disorder is evaluated to evaluate tubular dysfunctions.